Optimized management of enfortumab vedotin-related dermatological toxicity.

Parriel E, Perego-Langlais A, Ingen-Housz-Oro S, Sibaud V

Open source

DOI
10.1111/jdv.70515
Published
2026 Jun 8
Container
Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jdv.70515,
  title = {Optimized management of enfortumab vedotin-related dermatological toxicity.},
  author = {Parriel E and Perego-Langlais A and Ingen-Housz-Oro S and Sibaud V},
  year = {2026},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.70515},
  url = {https://doi.org/10.1111/jdv.70515}
}

RIS

TY  - JOUR
TI  - Optimized management of enfortumab vedotin-related dermatological toxicity.
AU  - Parriel E
AU  - Perego-Langlais A
AU  - Ingen-Housz-Oro S
AU  - Sibaud V
PY  - 2026
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.70515
UR  - https://doi.org/10.1111/jdv.70515
ER  - 

APA

E, P., A, P., S, I., & V, S. (2026). Optimized management of enfortumab vedotin-related dermatological toxicity.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70515

Source records